The Searle Company Limited (PSX:SEARL)
127.54
+3.89 (3.15%)
At close: Jan 16, 2026
The Searle Company Market Cap
The Searle Company has a market cap or net worth of 72.73 billion as of January 16, 2026. Its market cap has increased by 32.87% in one year.
Market Cap
72.73B
Enterprise Value
81.00B
Revenue
30.67B
Ranking
n/a
PE Ratio
51.33
Stock Price
127.54
Market Cap Chart
Since January 8, 1996, The Searle Company's market cap has increased from 451.86M to 72.73B, an increase of 15,996.28%. That is a compound annual growth rate of 18.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 75.02B | 6.31% |
| Dec 31, 2025 | 70.57B | 32.07% |
| Dec 31, 2024 | 53.43B | 166.08% |
| Dec 29, 2023 | 20.08B | -12.55% |
| Dec 30, 2022 | 22.96B | -48.80% |
| Dec 31, 2021 | 44.85B | -15.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 135.90B |
| Abbott Laboratories (Pakistan) | 119.25B |
| AGP Limited | 61.31B |
| Highnoon Laboratories | 55.13B |
| Shifa International Hospitals | 35.70B |
| Citi Pharma | 19.66B |
| Ferozsons Laboratories | 17.84B |
| Macter International | 15.62B |